Analysis of checkpoint responses to histone deacetylase inhibitors

Heather Beamish1, Robyn Warrener, Brian G Gabrielli

  • 1Centre for Immunology and Cancer Research, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.

Insights

Histone deacetylase inhibitors trigger cell cycle arrests by affecting chromatin acetylation. This study analyzes the G2 checkpoint response to these inhibitors using synchronized cell populations.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cell cycle checkpoints are crucial for maintaining genomic integrity against cellular stress.
  • Genotoxic agents inducing DNA damage are well-known activators of cell cycle checkpoints.
  • Histone deacetylase inhibitors (HDACi) alter chromatin structure and induce cell cycle perturbations, including G1 and G2 arrests.

Purpose of the Study:

  • To investigate the mechanism of the G2 phase cell cycle arrest induced by histone deacetylase inhibitors.
  • To analyze the specific checkpoint response triggered by HDACi in the G2 phase.

Main Methods:

  • Utilizing synchronized cell populations for precise temporal analysis.
  • Treating cells with specific histone deacetylase inhibitors.
  • Monitoring cell cycle progression and checkpoint activation.

Main Results:

  • Histone deacetylase inhibitors induce a significant G2 phase arrest.
  • This G2 arrest is mediated by an active checkpoint response.
  • Analysis of synchronized cells reveals the kinetics of this checkpoint activation.

Conclusions:

  • The G2 checkpoint is sensitive to perturbations caused by histone deacetylase inhibitors.
  • HDACi-induced G2 arrest provides a model for studying checkpoint regulation.
  • Understanding this response is key to exploring HDACi in therapeutic contexts.